Three separate papers last week reported different new insights into isocitrate dehydrogenase 1, or IDH1, an enzyme that is critical in the altered metabolism of cancer cells. Two papers came out of Memorial Sloan-Kettering Cancer Center, the third out of the Dana-Farber Cancer Institute.